APA (7th ed.) Citation

Stagno, F., Stella, S., Leotta, S., Caserta, S., Vitale, S. R., Markovic, U., . . . Allegra, A. (2025). No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR: :ABL1 Transcript Level. International Journal of Molecular Sciences, 26(5), 1840. https://doi.org/10.3390/ijms26051840

Chicago Style (17th ed.) Citation

Stagno, Fabio, et al. "No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR: :ABL1 Transcript Level." International Journal of Molecular Sciences 26, no. 5 (2025): 1840. https://doi.org/10.3390/ijms26051840.

MLA (9th ed.) Citation

Stagno, Fabio, et al. "No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR: :ABL1 Transcript Level." International Journal of Molecular Sciences, vol. 26, no. 5, 2025, p. 1840, https://doi.org/10.3390/ijms26051840.